Prevalence, Classifications and Factors Associated With Sexual Dysfunction among Adult Cancer Patients on Chemotherapy at Uganda Cancer Institute, Mbarara

Author:

Oenga Joel Nyanchiri1,Tamukong Robert1,Isiiko John1,Gibu Sibali Gidimali1,Yadesa Tadele Mekuriya1,Kule Gidion1

Affiliation:

1. Mbarara University of Science and Technology

Abstract

Abstract

Background: Sexual dysfunction is one of the social challenges that devastate many people among them cancer patients, but which is considered non-medical and often disregarded. Chemotherapeutics used among cancer patients are potential risk factors for development of SD and such understanding of these risk factors can lead to numerous interventions to bypass their effects on sexual life. Objective: The goal of this study was to determine the prevalence, classifications and factors associated with sexual dysfunctions among cancer patients on chemotherapy. Methods: A cross-sectional study was conducted among 214 cancer patients at the Mbarara Regional Referral Hospital in south western Uganda for a period of 3 months from August to October 2023. A systematic sampling technique was employed in the study; a questionnaire was used to collect patient data. Standardized female sexual function index and international index of erectile function tools were used to classify types of sexual dysfunctions among women and men respectively. Sexual dysfunction associated factors were analyzed by logistic regression using stata version 17. Results: Two hundred and fourteen participants were enrolled 127 males and 87 females with a median age of 50 years; overall 90 (42.06%) of the patients, 68 (54.33 %) of males and 21 (24.14%) of females) experienced at least one domain of sexual dysfunction. At presentation majority of men 43 (33.86%) reported overall sexual dissatisfaction, while majority of the female 15 (18.39%) patients reported decreased sexual desire others being reduced arousal and vaginal pain. The multivariate logistic regression identified the independent risk factors for sexual dysfunctions: female gender (aOR 3.99, 95% CI 1.93-8.25; p value =0.001), Gastro intestinal cancers (aOR 3.46, 95% CI 1.34-8.93; p value =0.010) and anthracyclines (aOR 4.26, 95% CI 1.02, 17.76; p value=0.047) were statistically significant independent risk factors of sexual dysfunctions. Conclusions: Our findings suggest that there is a high prevalence of sexual dysfunctions among cancer patients at the Mbarara Regional Referral Hospital. In male patients, the overall sexual dissatisfaction is the most prevalent while decreased sexual desire is prevalent in female. Routine screening of sexual functions should be encouraged among all patients receiving chemotherapies. Female patients, those diagnosed with gastro-intestinal cancers, and those on regimens containing anthracyclines should be more closely monitored for sexual dysfunction.

Publisher

Research Square Platform LLC

Reference31 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung H;CA Cancer J Clin,2021

2. Globocan. Cancer today [Internet]. 2020 [cited 2024 Jan 20]. http://gco.iarc.fr/today/home.

3. maiorino et al. 2022 [Internet]. [cited 2023 Mar 29]. https://link.springer.com/article/10.1007/s40618-018-0872-6.

4. The Effect of Technology-Based Interventions on Pain, Depression, and Quality of Life in Patients With Cancer: A Systematic Review of Randomized Controlled Trials;Agboola SO;J Med Internet Res,2015

5. Chen CH, Lin YC, Chiu LH, Chu YH, Ruan FF, Liu WM et al. Female sexual dysfunction: Definition, classification, and debates. Taiwanese Journal of Obstetrics and Gynecology [Internet]. 2013 Mar 1 [cited 2022 Oct 3];52(1):3–7. https://www.sciencedirect.com/science/article/pii/S102845591300003X.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3